VERU INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
VERU INC. (VERU) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $3.20 million for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2020-12-10
- VERU INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $3.20M.
- VERU INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was $9.90M, a 4.79% increase from fiscal 2012.
- VERU INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2012 was $9.45M, a 101.13% increase from fiscal 2011.
- VERU INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2011 was $4.70M, a 16.13% decline from fiscal 2010.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2020-09-30 | $3.20M 10-K · filed 2020-12-10 | |
| 2013-09-30 | $9.90M 10-K · filed 2013-12-03 | |
| 2012-09-30 | $9.45M 10-K · filed 2013-12-03 | $9.91M 10-K · filed 2012-12-04 |
| 2011-09-30 | $4.70M 10-K · filed 2013-12-03 | |
| 2010-09-30 | $5.60M 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |